Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study.

Clicks: 284
ID: 29407
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #175 of 296 articles by views in Journal of medical Internet research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 296 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Current clinical assessments of people with multiple sclerosis are episodic and may miss critical features of functional fluctuations between visits.The goal of the research was to assess the feasibility of remote active testing and passive monitoring using smartphones and smartwatch technology in persosns with multiple sclerosis with respect to adherence and satisfaction with the FLOODLIGHT test battery.Persons with multiple sclerosis (aged 20 to 57 years; Expanded Disability Status Scale 0-5.5; n=76) and healthy controls (n=25) performed the FLOODLIGHT test battery, comprising active tests (daily, weekly, every two weeks, or on demand) and passive monitoring (sensor-based gait and mobility) for 24 weeks using a smartphone and smartwatch. The primary analysis assessed adherence (proportion of weeks with at least 3 days of completed testing and 4 hours per day passive monitoring) and questionnaire-based satisfaction. In-clinic assessments (clinical and magnetic resonance imaging) were performed.Persons with multiple sclerosis showed 70% (16.68/24 weeks) adherence to active tests and 79% (18.89/24 weeks) to passive monitoring; satisfaction score was on average 73.7 out of 100. Neither adherence nor satisfaction was associated with specific population characteristics. Test-battery assessments had an at least acceptable impact on daily activities in over 80% (61/72) of persons with multiple sclerosis.Persons with multiple sclerosis were engaged and satisfied with the FLOODLIGHT test battery. FLOODLIGHT sensor-based measures may enable continuous assessment of multiple sclerosis disease in clinical trials and real-world settings.ClinicalTrials.gov: NCT02952911; https://clinicaltrials.gov/ct2/show/NCT02952911.
Reference Key
midaglia2019adherencejournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Midaglia, Luciana;Mulero, Patricia;Montalban, Xavier;Graves, Jennifer;Hauser, Stephen L;Julian, Laura;Baker, Michael;Schadrack, Jan;Gossens, Christian;Scotland, Alf;Lipsmeier, Florian;van Beek, Johan;Bernasconi, Corrado;Belachew, Shibeshih;Lindemann, Michael;
Journal Journal of medical Internet research
Year 2019
DOI
10.2196/14863
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.